Philip Bejon/BMC Infect Dis
Pre-COVID-19 ex vivo cross-reactive IFN-gamma cellular response to SARS-CoV-2 spike overlapping peptides is more prevalent among Kenyan compared to Swedish adults.Wanjiku, P.
Orindi, B.
Mwacharo, J.
Chemweno, J.
Karanja, H. K.
Kronsteiner, B.
Kai, O.
Wright, D.
Ochola-Oyier, L. I.
Sundling, C.
Dunachie, S.
Warimwe, G. M.
Farnert, A.
Bejon, P.
Ndungu, F. M.
Nduati, E. W.
BMC Infect Dis, (2026). 26:174
Detection of low frequency artemisinin resistance mutations, C469Y, P553L and A675V, and fixed antifolate resistance mutations in asymptomatic primary school children in Kenya.Osoti, V.
Wamae, K.
Ndwiga, L.
Gichuki, P. M.
Okoyo, C.
Kepha, S.
Keitany, K.
Kandie, R.
Aricha, S.
Kiplagat, R.
Mwandawiro, C.
Bejon, P.
Snow, R. W.
Ochola-Oyier, L. I.
BMC Infect Dis, (2025). 25:73
Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya.Lugano, D.
Kutima, B.
Kimani, M.
Sigilai, A.
Gitonga, J.
Karani, A.
Akech, D.
Karia, B.
Ziraba, A. K.
Maina, A.
Lambisia, A.
Omuoyo, D.
Mugo, D.
Lucinde, R.
Owuor, S.
Konyino, G.
Newman, J.
Bailey, D.
Nduati, E.
Githinji, G.
Agoti, C. N.
Bejon, P.
Scott, J. A. G.
Agweyu, A.
Kagucia, W.
Warimwe, G. M.
Sande, C.
Ochola-Oyier, L. I.
Nyagwange, J.
BMC Infect Dis, (2024). 24:1474
Prospective clinical surveillance for severe acute respiratory illness and COVID-19 vaccine effectiveness in Kenyan hospitals during the COVID-19 pandemic.Lucinde, R. K.
Gathuri, H.
Isaaka, L.
Ogero, M.
Mumelo, L.
Kimego, D.
Mbevi, G.
Wanyama, C.
Otieno, E. O.
Mwakio, S.
Saisi, M.
Isinde, E.
Oginga, I. N.
Wachira, A.
Manuthu, E.
Kariuki, H.
Nyikuli, J.
Wekesa, C.
Otedo, A.
Bosire, H.
Okoth, S. B.
Ongalo, W.
Mukabi, D.
Lusamba, W.
Muthui, B.
Adembesa, I.
Mithi, C.
Sood, M.
Ahmed, N.
Gituma, B.
Giabe, M.
Omondi, C.
Aman, R.
Amoth, P.
Kasera, K.
Were, F.
Nganga, W.
Berkley, J. A.
Tsofa, B.
Mwangangi, J.
Bejon, P.
Barasa, E.
English, M.
Scott, J. A. G.
Akech, S.
Kagucia, E. W.
Agweyu, A.
Etyang, A. O.
BMC Infect Dis, (2024). 24:1246
Distinct transcriptomic signatures define febrile malaria depending on initial infective states, asymptomatic or uninfected.Kimenyi, K. M.
Akinyi, M. Y.
Mwikali, K.
Gilmore, T.
Mwangi, S.
Omer, E.
Gichuki, B.
Wambua, J.
Njunge, J.
Obiero, G.
Bejon, P.
Langhorne, J.
Abdi, A.
Ochola-Oyier, L. I.
BMC Infect Dis, (2024). 24:140
Endemic chikungunya fever in Kenyan children: a prospective cohort study.Nyamwaya, D. K.
Otiende, M.
Omuoyo, D. O.
Githinji, G.
Karanja, H. K.
Gitonga, J. N.
R. de Laurent Z
Otieno, J. R.
Sang, R.
Kamau, E.
Cheruiyot, S.
Otieno, E.
Agoti, C. N.
Bejon, P.
Thumbi, S. M.
Warimwe, G. M.
BMC Infect Dis, (2021). 21:186
Trends in bednet ownership and usage, and the effect of bednets on malaria hospitalization in the Kilifi Health and Demographic Surveillance System (KHDSS): 2008-2015.Kamau, A.
Nyaga, V.
Bauni, E.
Tsofa, B.
Noor, A. M.
Bejon, P.
Scott, J. A. G.
Hammitt, L. L.
BMC Infect Dis, (2017). 17:720
Plasmodium falciparum malaria parasite var gene expression is modified by host antibodies: longitudinal evidence from controlled infections of Kenyan adults with varying natural exposure.Abdi, A. I.
Hodgson, S. H.
Muthui, M. K.
Kivisi, C. A.
Kamuyu, G.
Kimani, D.
Hoffman, S. L.
Juma, E.
Ogutu, B.
Draper, S. J.
Osier, F.
Bejon, P.
Marsh, K.
Bull, P. C.
BMC Infect Dis, (2017). 17:585
